Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway

Overcoming temozolomide (TMZ) resistance is a great challenge in glioblastoma (GBM) treatment. Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in the biosynthesis of nicotinamide adenine dinucleotide and has a crucial role in cancer cell metabolism. In this study, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jun, Yan, Peng-Fei, Zhao, Hong-yang, Zhang, Fang-Cheng, Zhao, Wo-Hua, Feng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206411/
https://www.ncbi.nlm.nih.gov/pubmed/28097126
http://dx.doi.org/10.1155/2016/1450843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206411/
https://www.ncbi.nlm.nih.gov/pubmed/28097126
http://dx.doi.org/10.1155/2016/1450843

Ejemplares similares